Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Truist Securities Maintains Hold on Amgen, Lowers Price Target to $260

Truist Securities analyst Robyn Karnauskas maintains Amgen (NASDAQ:AMGN) with a Hold and lowers the price target from $280 to $260.
byBenzinga Newsdesk
February 13, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Truist Securities analyst Robyn Karnauskas maintains Amgen (NASDAQ:AMGN) with a Hold and lowers the price target from $280 to $260.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts